Correlation Between Regen BioPharma and Protokinetix

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Regen BioPharma and Protokinetix at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Regen BioPharma and Protokinetix into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Regen BioPharma and Protokinetix, you can compare the effects of market volatilities on Regen BioPharma and Protokinetix and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Regen BioPharma with a short position of Protokinetix. Check out your portfolio center. Please also check ongoing floating volatility patterns of Regen BioPharma and Protokinetix.

Diversification Opportunities for Regen BioPharma and Protokinetix

0.23
  Correlation Coefficient

Modest diversification

The 3 months correlation between Regen and Protokinetix is 0.23. Overlapping area represents the amount of risk that can be diversified away by holding Regen BioPharma and Protokinetix in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Protokinetix and Regen BioPharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Regen BioPharma are associated (or correlated) with Protokinetix. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Protokinetix has no effect on the direction of Regen BioPharma i.e., Regen BioPharma and Protokinetix go up and down completely randomly.

Pair Corralation between Regen BioPharma and Protokinetix

Given the investment horizon of 90 days Regen BioPharma is expected to generate 1.93 times more return on investment than Protokinetix. However, Regen BioPharma is 1.93 times more volatile than Protokinetix. It trades about 0.06 of its potential returns per unit of risk. Protokinetix is currently generating about 0.04 per unit of risk. If you would invest  94.00  in Regen BioPharma on September 4, 2024 and sell it today you would lose (88.49) from holding Regen BioPharma or give up 94.14% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Regen BioPharma  vs.  Protokinetix

 Performance 
       Timeline  
Regen BioPharma 

Risk-Adjusted Performance

8 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Regen BioPharma are ranked lower than 8 (%) of all global equities and portfolios over the last 90 days. Even with relatively inconsistent fundamental drivers, Regen BioPharma reported solid returns over the last few months and may actually be approaching a breakup point.
Protokinetix 

Risk-Adjusted Performance

2 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Protokinetix are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. In spite of fairly weak basic indicators, Protokinetix showed solid returns over the last few months and may actually be approaching a breakup point.

Regen BioPharma and Protokinetix Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Regen BioPharma and Protokinetix

The main advantage of trading using opposite Regen BioPharma and Protokinetix positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Regen BioPharma position performs unexpectedly, Protokinetix can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Protokinetix will offset losses from the drop in Protokinetix's long position.
The idea behind Regen BioPharma and Protokinetix pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Companies Directory module to evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals.

Other Complementary Tools

Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes